Thus, we find an increase of mature CD57+ CD56dim NK cells in CLL patients, but the expression of most activating and inhibitory receptors on CLL-derived NK cells is similar to HC NK cells, except for NKG2D. This evidence concerns the gene KLRK1 and B-cell chronic lymphocytic leukemia.